Trial
NCT04534283
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Anita Turk
Collaborators
Eli Lilly and Company
Condition
Cancer
Intervention
Abemaciclib
Why stopped
Lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-07